Ilant Health Founder & CEO Elina Onitskanky. Image: Ilant Health

Ilant Health, a company active in in value-based obesity management and cardiometabolic health, has announced an extension of its seed round of fundraising from $3 million to $5.5 million. The additional funds were secured from new health-oriented investors, including LifeX Ventures, Celtic House Asia Partners, and Cornucopian Capital, along with existing investors reaffirming their commitment.

Elina Onitskanky, CEO of Ilant Health, founded the company knowing that the gender gap in venture capital funding meant only 2% of funding goes toward women founders. However, Ilant has benefited from the steadfast support of healthcare leaders and other women leaders and investors, who helped shape the company into where it is today.

The decision to extend the seed round follows Ilant’s growing traction. The company has received recognition, winning all three World 50 Group Academies — EHIR, HPIR, and PHIR — and earning a spot in Highmark and Allegheny Health Network’s accelerator, AlphaLab Health. Ilant Health also won the Employee Health Innovation Roundtable (EHIR) Traction Award. So far Ilant Health has launched clinical services to multiple employers and the use of its claims analytics for hundreds of thousands of lives. The company’s claims analytics, driven by unstructured machine learning, have provided insights into reductions in total cost of care and return on investment from obesity treatment.

As part of this raise, Ilant has engaged prominent industry advisors, including Teri Wisness, former Director of U.S. Benefits at Google, and Meghan Fitzgerald, former executive at Cardinal Health.

Show CommentsClose Comments

Leave a comment